Furthermore, we confirmed the diagnostic efficacy of PLOD3 and LRRN3 for PD via collected blood samples derived from 35 patients with a clinical diagnosis of PD and 23 controls in our hospital. This evidence concerns the gene LRRN3 and Parkinson disease.